{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:54:48Z","timestamp":1792601688965,"version":"4.5.0"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Coinfection of tuberculosis or nontuberculous mycobacteria and <jats:italic toggle=\"yes\">Aspergillus<\/jats:italic> presents a challenge in medication selection because of the pharmacokinetic interactions between rifampin and voriconazole. Some researchers have suggested the use of rifabutin as an alternative to rifampin because of its lower hepatic cytochrome P450 enzyme induction potency despite its contraindication to drug labels. This study presents clinical cases of voriconazole and rifabutin coadministration and their potential risks.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>This retrospective study was conducted using clinical data from patients who met the following criteria: (1) admitted to Seoul National University Hospital between July 2014 and August 2023 and (2) concurrently administered rifabutin and voriconazole for more than 5 days.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Among the 6 patients analyzed, 4 experienced adverse drug reactions (ADRs). Three patients experienced visual and auditory hallucinations, lower extremity numbness, or delirious behavior. Two patients had prolonged the time from the start of the Q wave to the end of the T wave intervals, and 1 had elevated aspartate aminotransferase and alanine aminotransferase levels. In addition, 2 patients experienced severe nausea, poor oral intake, and weight loss. Despite receiving 1.81-fold the recommended voriconazole dosage, a therapeutic concentration (1.0\u20135.5 mg\/L) was not achieved because of cytochrome P450 induction by rifabutin. However, during septic shock, the voriconazole concentration increased by 13.7- to 36-fold.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Concurrent use of rifabutin and voriconazole was associated with ADRs, including the time from the start of the Q wave to the end of the T wave prolongation, hallucinations, and severe nausea. Moreover, initially, there was a significant decrease in voriconazole concentrations; however, these concentrations substantially increased during septic shock. Therefore, it is essential to monitor drug concentrations and ADRs during concurrent use of voriconazole and rifabutin.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ftd.0000000000001241","type":"journal-article","created":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T14:16:05Z","timestamp":1721312165000},"page":"303-308","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Coadministration of Voriconazole and Rifabutin Can Increase the Risk of Adverse Drug Reactions in Patients With Multiple Infections"],"prefix":"10.1097","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-2141-2407","authenticated-orcid":false,"given":"Yoonjin","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungyeun","family":"Bae","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki Young","family":"Huh","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Sun","family":"Joo","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Seoul National University Hospital, Seoul, Republic of Korea;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jikyo","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Seoul National University Hospital, Seoul, Republic of Korea;"},{"name":"Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Hoon","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Seoul National University Hospital, Seoul, Republic of Korea;"},{"name":"Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung-Sang","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In-Jin","family":"Jang","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6275-8587","authenticated-orcid":false,"given":"Jaeseong","family":"Oh","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea;"},{"name":"Department of Pharmacology, Jeju National University College of Medicine, Jeju, Republic of Korea;"},{"name":"Jeju National University Hospital Clinical Research Institute, Jeju, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,7,16]]},"reference":[{"key":"R1-20250314","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1093\/jac\/dkt229","article-title":"Steady-state pharmacokinetics and metabolism of voriconazole in patients","volume":"68","author":"Geist","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"R2-20250314","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3390\/pharmaceutics14030477","article-title":"Towards the elucidation of the pharmacokinetics of voriconazole: a quantitative characterization of its metabolism","volume":"14","author":"Schulz","year":"2022","journal-title":"Pharmaceutics"},{"key":"R3-20250314","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1476-0711-5-3","article-title":"Roles of rifampicin in drug-drug interactions: underlying molecular mechanisms involving the nuclear pregnane X receptor","volume":"5","author":"Chen","year":"2006","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"R4-20250314","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/jcpt.12493","article-title":"The influence of combination use of CYP450 inducers on the pharmacokinetics of voriconazole: a systematic review","volume":"42","author":"Li","year":"2017","journal-title":"J Clin Pharm Ther"},{"key":"R5-20250314","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1592\/phco.28.8.1076","article-title":"Concomitant use of voriconazole and rifabutin in a patient with multiple infections","volume":"28","author":"Schwiesow","year":"2008","journal-title":"Pharmacotherapy"},{"key":"R7-20250314","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0009-2797(99)00089-7","article-title":"Comparative effects of rifabutin and rifampicin on cytochromes P450 and UDP-glucuronosyl-transferases expression in fresh and cryopreserved human hepatocytes","volume":"121","author":"Reinach","year":"1999","journal-title":"Chem Biol Interact"},{"key":"R8-20250314","doi-asserted-by":"crossref","first-page":"6366","DOI":"10.1128\/AAC.01124-13","article-title":"Induction of influx and efflux transporters and cytochrome P450 3A4 in primary human hepatocytes by rifampin, rifabutin, and rifapentine","volume":"57","author":"Williamson","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"R9-20250314","doi-asserted-by":"crossref","first-page":"e0104321","DOI":"10.1128\/AAC.01043-21","article-title":"Model-based comparative analysis of rifampicin and rifabutin drug-drug interaction profile","volume":"65","author":"Tuloup","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"R10-20250314","doi-asserted-by":"crossref","first-page":"e00537","DOI":"10.1016\/j.idcr.2019.e00537","article-title":"Invasive pulmonary aspergillosis and pulmonary tuberculosis in a patient treated with infliximab for Crohn's disease","volume":"17","author":"Buonomo","year":"2019","journal-title":"IDCases"},{"key":"R11-20250314","first-page":"003249","article-title":"Concomitant pulmonary tuberculosis and invasive aspergillosis infection in an immunocompetent host","volume":"9","author":"Ahmed","year":"2022","journal-title":"Eur J Case Rep Intern Med"},{"key":"R14-20250314","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1345\/aph.1H671","article-title":"Adverse effects of voriconazole: analysis of the French Pharmacovigilance Database","volume":"41","author":"Eiden","year":"2007","journal-title":"Ann Pharmacother"},{"key":"R15-20250314","first-page":"739","article-title":"Neurological adverse events to voriconazole: evidence for therapeutic drug monitoring","volume":"136","author":"Imhof","year":"2006","journal-title":"Swiss Med Wkly"},{"key":"R16-20250314","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.4254\/wjh.v7.i14.1828","article-title":"Voriconazole and the liver","volume":"7","author":"Mihaila","year":"2015","journal-title":"World J Hepatol"},{"key":"R17-20250314","doi-asserted-by":"crossref","first-page":"7475","DOI":"10.2147\/IDR.S391022","article-title":"Central nervous system toxicity of voriconazole: risk factors and threshold - a retrospective cohort study","volume":"15","author":"Yang","year":"2022","journal-title":"Infect Drug Resist"},{"key":"R18-20250314","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1517\/14740330903485637","article-title":"Voriconazole therapeutic drug monitoring: focus on safety","volume":"9","author":"Pasqualotto","year":"2010","journal-title":"Expert Opin Drug Saf"},{"key":"R19-20250314","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1056\/NEJM199608083350603","article-title":"A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome","volume":"335","author":"Pierce","year":"1996","journal-title":"N Engl J Med"},{"key":"R20-20250314","doi-asserted-by":"crossref","first-page":"ofaa460","DOI":"10.1093\/ofid\/ofaa460","article-title":"Pharmacology, dosing, and side effects of rifabutin as a possible therapy for antibiotic-resistant acinetobacter infections","volume":"7","author":"Phillips","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"R21-20250314","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jac\/dkw349","article-title":"Voriconazole metabolism is influenced by severe inflammation: a prospective study","volume":"72","author":"Veringa","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"R22-20250314","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.3390\/genes11121509","article-title":"Distinct effects of inflammation on cytochrome P450 regulation and drug metabolism: lessons from experimental models and a potential role for pharmacogenetics","volume":"11","author":"de Jong","year":"2020","journal-title":"Genes (Basel)"},{"key":"R23-20250314","doi-asserted-by":"crossref","first-page":"733935","DOI":"10.3389\/fphar.2021.733935","article-title":"Influence of inflammation on cytochromes P450 activity in adults: a systematic review of the literature","volume":"12","author":"Lenoir","year":"2021","journal-title":"Front Pharmacol"},{"key":"R24-20250314","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1124\/dmd.107.015511","article-title":"Gene-specific effects of inflammatory cytokines on cytochrome P450 2C, 2B6 and 3A4 mRNA levels in human hepatocytes","volume":"35","author":"Aitken","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"R25-20250314","doi-asserted-by":"crossref","first-page":"923","DOI":"10.2174\/138920012802138589","article-title":"De-risking bio-therapeutics for possible drug interactions using cryopreserved human hepatocytes","volume":"13","author":"Dallas","year":"2012","journal-title":"Curr Drug Metab"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001241","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T15:03:16Z","timestamp":1741964596000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,16]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000001241","relation":{},"ISSN":["0163-4356","1536-3694"],"issn-type":[{"value":"0163-4356","type":"print"},{"value":"1536-3694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,16]]},"assertion":[{"value":"2023-12-24","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-08","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}